Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Phase 1 Study Evaluating CPI-0610 in Patients With Progressive Lymphoma

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2016 by Constellation Pharmaceuticals
The Leukemia and Lymphoma Society
Information provided by (Responsible Party):
Constellation Pharmaceuticals Identifier:
First received: September 10, 2013
Last updated: April 6, 2016
Last verified: April 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2016
  Estimated Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)